Genotyping human arylamine N-acetyltransferase type 1 (NAT1). The identification of two novel allelic variants

Biochemical Pharmacology

Volumn 55, Issue 3, 1998, Pages 361-366

  Payton, Mark A ^a   Sim, Edith ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetyltransferase; Arylamine; genotype; NAT; PCR RFLP; Phenotype

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; ISOENZYME;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENOTYPE; HUMAN; HUMAN TISSUE; MUTATION; NORMAL HUMAN; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ALLELES; ARYLAMINE N-ACETYLTRANSFERASE; BASE SEQUENCE; DNA; GENOTYPE; HUMANS; ISOENZYMES; MOLECULAR SEQUENCE DATA; PHENOTYPE; VARIATION (GENETICS);

EID: 0032007525     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00478-4     Document Type: Article

References (28)

1. Risch A, Smelt V, Lane D, Stanely L, van der Slot W, Ward A, Sim E. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients. Pharmacol Toxicol. 78:1996;235-240.
2. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA, Willett WC, Speizer FE. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst. 86:1994;192-199.
3. Potter JD, Slattery ML, Bostick RM, Gapstur SM. Colon cancer a review of the epidemiology . Epidemiol Rev. 15:1993;499-545.
4. Smith G, Stanley LA, Sim E, Strange RC, Wolf CR. Metabolic polymorphisms and cancer susceptibility. Cancer Surv. 25:1995;27-65.
5. The Office of Population Censuses and Surveys (OPCS). Cancer statistics registration - Registrations of cancer diagnosed in 1988, England and Wales. London: HMSO, 1994.
6. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Kadlubar F, Bartsch H, Vineis P. Carcinogen-DNA adducts in exfoliated urothelial cells techniques for noninvasive human monitoring . Environ Health Perspect. 99:1993;289-291.
7. Wallace DMA. Occupational urothelial cancer. Br J Urol. 61:1988;175-182.
8. Case RA, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Brit J Ind Med. 11:1954;75-104.
9. Ambrosone CB, Freudenhein JL, Graham S, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemeto T, Gillenwater KA, Harrington AM, Sheilds PG. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. JAMA. 276:1996;1494-1501.
10. Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55:1995;5230-5237.
11. Andres HH, Klem AJ, Schopfer LM, Harrison JK, Weber WW. On the active site of liver acetyl-CoA arylamine N-acetyltransferase from rapid acetylator rabbits (111/J). J Biol Chem. 263:1988;7521-7527.
12. Andres HH, Kolb HJ, Schreiber RJ, Weiss L. Characterisation of the active site, substrate specificity and kinetic properties of acetyl-CoA arylamine N-acetyltransferase from pigeon liver . Bioch Biophys Acta. 746:1983;193-201.
13. Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes isolation, chromosomal localization, and functional expression . DNA Cell Biol. 9:1990;193-203.
14. Matas N, Thygesen P, Stacey M, Risch A, Sim E. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferases, carcinogen metabolising enzymes of human chromosome 8p22, a region frequently deleted in tumours. Cytogen Cell Genet. 77:1997;290-295.
15. Hearse DJ, Weber WW. Multiple N-acetyltransferases and drug metabolism. Biochem J. 132:1973;519-526.
16. Pacifici GM, Bencini C, Rane A. Acetyltransferase in humans development and tissue distribution . Pharmacology. 32:1986;283-291.
17. Risch A, Wallace DM, Bathers S, Sim E. Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet. 4:1995;231-236.
18. Grant DM, Morike K, Eichelbaum M, Meyer UA. Acetylation pharmacogenetics The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver . J Clin Invest. 85:1990;968-972.
19. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DA, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y. Nomenclature for N-acetyltransferases. Pharmacogenetics. 5:1995;1-17.
20. DiLella AG, Woo SL. Cloning large segments of genomic DNA using cosmid vectors. Methods Enzymol. 152:1987;199-212.
21. Bell DA, Stephens EA, Castranio T, Umbach DM, Watson M, Deakin M, Elder J, Hendrickse C, Duncan H, Strange RC. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res. 55:1995;3537-3542.
22. Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL, Grewal R. Human acetyltransferase polymorphisms. Mut Res. 376:1997;61-70.
23. Sinclair J, Sim E. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyl transferase one (NAT1) and the first transacetylation step of catalysis. Biochem Pharmacol. 53:1997;11-16.
24. Hickman D, Pope J, Patil SD, Fakis G, Stanely LA, Payton M, Unadkat JP and Sim E, Expression of arylamine N-acetyltransferase in human intestine. Gut. (In press), 1997.
25. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue . Cancer Res. 55:1995;5226-5229.
26. Probst-Hensch NM, Haile RW, Li DS, Sakamoto GT, Louie AD, Lin BK, Frankl HD, Lee ER, Lin HJ. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas. Carcinogenesis. 17:1996;2125-2129.
27. Minchin RF. Acetylation of para-aminobenzoylglutamate, a folate catabolite, by recombinant human NAT and U937 cells. Biochem J. 307:1995;1-3.
28. Ward A, Hickman D, Gordon JW, Sim E. Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol. 44:1992;1099-1104.